Clinical Trials Directory

Trials / Completed

CompletedNCT07076628

Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care

Incidence of Respiratory Depression of Remimazolam Compared With Propofol for Monitored Anesthesia Care During Hysteroscopy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
76 (actual)
Sponsor
DongGuk University · Academic / Other
Sex
Female
Age
19 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The comparison of incidence of respiratory depression between remimazolam and propofol under monitored anesthesia care for hysteroscopic surgery

Detailed description

* Non-invasive blood pressure, electrocardiogram, and oxygen saturation sensors are attached. * Wear an oxygen mask (5L per minute), and place the sampling line for end-tidal carbon dioxide partial pressure measurement inside the nose. * Check the randomization table to determine the drug to be administered, and prepare propofol or remimazolam accordingly. * Record the baseline values (0 min). * Start administration of Remifentanil. ⑥ Administer anesthesia to adjust the maintenance dose to reach a sedation level of 2 or less on the MOAA/S scale. ⑦ Adjust the remifentanil dose according to the patient's response ⑧ When the target sedation level is reached, the surgical preparation process and surgery begin, and the study variables are observed and recorded at 5-minute intervals. ⑨ Stop drug administration upon end of surgery. ⑩ After confirming proper recovery of consciousness and spontaneous breathing, leave the recovery room. ⑪ Before leaving the recovery room, check the complete recovery and investigate the patient's satisfaction with anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGPropofolPropofol infusion with remifentanil
DRUGRemimazolamRemimazolam infusion with remifentanil

Timeline

Start date
2023-08-24
Primary completion
2025-05-30
Completion
2025-05-30
First posted
2025-07-22
Last updated
2025-07-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07076628. Inclusion in this directory is not an endorsement.